EconPapers    
Economics at your fingertips  
 

Rational design of universal immunotherapy for TfR1-tropic arenaviruses

Hadas Cohen-Dvashi, Ron Amon, Krystle N. Agans, Robert W. Cross, Aliza Borenstein-Katz, Mathieu Mateo, Sylvain Baize, Vered Padler-Karavani, Thomas W. Geisbert and Ron Diskin ()
Additional contact information
Hadas Cohen-Dvashi: Weizmann Institute of Science
Ron Amon: Tel Aviv University
Krystle N. Agans: University of Texas Medical Branch
Robert W. Cross: University of Texas Medical Branch
Aliza Borenstein-Katz: Weizmann Institute of Science
Mathieu Mateo: Centre International de Recherche en Infectiologie (INSERM, CNRS, ENS Lyon, Université Lyon I)
Sylvain Baize: Centre International de Recherche en Infectiologie (INSERM, CNRS, ENS Lyon, Université Lyon I)
Vered Padler-Karavani: Tel Aviv University
Thomas W. Geisbert: University of Texas Medical Branch
Ron Diskin: Weizmann Institute of Science

Nature Communications, 2020, vol. 11, issue 1, 1-11

Abstract: Abstract Certain arenaviruses that circulate in rodent populations can cause life-threatening hemorrhagic fevers when they infect humans. Due to their efficient transmission, arenaviruses pose a severe risk for outbreaks and might be exploited as biological weapons. Effective countermeasures against these viruses are highly desired. Ideally, a single remedy would be effective against many or even all the pathogenic viruses in this family. However, despite the fact that all pathogenic arenaviruses from South America utilize transferrin receptor 1 (TfR1) as a cellular receptor, their viral glycoproteins are highly diversified, impeding efforts to isolate cross-neutralizing antibodies. Here we address this problem using a rational design approach to target TfR1-tropic arenaviruses with high potency and breadth. The pan-reactive molecule is highly effective against all arenaviruses that were tested, offering a universal therapeutic approach. Our design scheme avoids the shortcomings of previous immunoadhesins and can be used to combat other zoonotic pathogens.

Date: 2020
References: Add references at CitEc
Citations: View citations in EconPapers (1)

Downloads: (external link)
https://www.nature.com/articles/s41467-019-13924-6 Abstract (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:natcom:v:11:y:2020:i:1:d:10.1038_s41467-019-13924-6

Ordering information: This journal article can be ordered from
https://www.nature.com/ncomms/

DOI: 10.1038/s41467-019-13924-6

Access Statistics for this article

Nature Communications is currently edited by Nathalie Le Bot, Enda Bergin and Fiona Gillespie

More articles in Nature Communications from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().

 
Page updated 2025-03-19
Handle: RePEc:nat:natcom:v:11:y:2020:i:1:d:10.1038_s41467-019-13924-6